# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BTIG analyst Michael Gorman maintains Alpine Income Prop Trust (NYSE:PINE) with a Buy and lowers the price target from $23 t...
Stifel analyst Nathan Jones maintains Alpine Income Prop Trust (NYSE:PINE) with a Buy and lowers the price target from $19 t...
JonesTrading analyst Jason Weaver maintains Alpine Income Prop Trust (NYSE:PINE) with a Buy and lowers the price target from...
Companies Reporting Before The Bell • Addex Therapeutics (NASDAQ:ADXN) is estimated to report earnings for its fourth quarter.
Alliance Global Partners analyst Gaurav Mehta initiates coverage on Alpine Income Prop Trust (NYSE:PINE) with a Buy rating a...
Alpine Income Property Trust, Inc. (NYSE:PINE) (the "Company") announced today that its Senior Vice President, Chief Fi...
JonesTrading analyst Jason Weaver maintains Alpine Income Prop Trust (NYSE:PINE) with a Buy and lowers the price target from...